Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-03-11

Clinical Trial Update: Effect of Vitamin D Supplementation on Erythropoietin Dosage in Hemodialysis Patients Who Have Vitamin D Deficiency

View source ↗

Summary

A trial evaluating the effect of Vitamin D supplementation on erythropoietin dosage in hemodialysis patients with Vitamin D deficiency has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D3 (Cholecalciferol) (Cholecalciferol)

Snippet

Sponsor: Kaiser Permanente | Conditions: Vitamin D Deficiency, Anemia | Status: WITHDRAWN